Mesothelioma Applied Research Foundation – “MARF” – Monoclonal antibody-drug-conjugate to target oncogenic ERK5 in mesothelioma

Project data

Funding Entity: Mesothelioma Applied Research Foundation (MARF)

Call: 2022-2023 Research Grant Cycle

Coordinator: Università di Siena (Italy)

UNISI Principal Investigator: Prof. Emanuele Giurisato

Department: Department of Biotechnology, Chemistry and Pharmacy (DBCF)

Start date: 1 July 2023

End date: 1 July 2025